[ad_1]
► Subscribe to 5 News: http://bit.ly/5NewsSub
► Hundreds of women with ovarian genetic cancer will benefit from a drug that charities describe as revolutionary. NHS regulators have approved Olaparib, also known as Lynparza, for wider use on the NHS in England.
This could prolong the lives of some patients – and even cure some cases of the disease.
► # 5News #News
► Follow 5 News:
Facebook: http://bit.ly/5NewsFB
Twitter: http://bit.ly/5NewsTwitter
► About 5 News: Channel 5 News covers the milestones of the day with the audacity of often carrying different reports to other news programs and placing people at the heart of its reporting.
The flagship 17 hour show is watched by nearly a million viewers. A later bulletin is broadcast at 6:30 pm and brief updates are made regularly throughout the day.
Channel 5 News operations are located in a custom Channel 5-based newsroom and linked to ITN's central technical, editorial and enterprise infrastructure.
ITN changed the television information landscape at the launch of 5 News in 1997, producing Five News for nine years before winning the Channel 5 news supply contract starting in 2012.
Source link
